EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion

Jia-Ru Wei, Baifeng Zhang iD, Yu Zhang, Wo-Ming Chen, Xiao-Ping Zhang, Ting-Ting Zeng, Yan Li iD, Ying-Hui Zhu iD, Xin-Yuan Guan iD, Lei Li iD

Proceedings of the National Academy of Sciences · 29.10.2024 · 121 (44)

DOI: 10.1073/pnas.2407506121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 21.10.2024. Verfasst von Jia-Ru Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medica…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, B7-H1 Antigen, Esophageal Neoplasms, Neoplastic Stem Cells. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Guangzhou science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dormant cancer stem cells (DCSCs) exhibit characteristics of chemotherapy resistance and immune escape, and they are a crucial source of tumor recurrence and metastasis. However, the underlying mechanisms remain unrevealed. We demonstrate that enriched Gzmk + CD8 + T cells within the niche of esophageal DCSCs restrict the outgrowth of tumor mass. Nonetheless, DCSCs can escape immune elimination by enhancing PD-L1 signaling, thereby maintaining immune equilibrium. Quiescent fibroblast-derived quiescin sulfhydryl oxidase 1 (QSOX1) promotes the expression of PD-L1 and its own expression in DCSCs by elevating the level of reactive oxygen species. Additionally, high QSOX1 in the dormant tumor niche contributes to the exclusion of CD8 + T cells. Conversely, blocking QSOX1 with Ebselen in combination with anti-PD-1 and chemotherapy can effectively eradicate residual DCSCs by reducing PD-L1 expression and promoting CD8 + T cell infiltration. Clinically, high expression of QSOX1 predicts a poor response to anti-PD-1 treatment in patients with esophageal cancer. Thus, our findings reveal a mechanism whereby QSOX1 promotes PD-L1 upregulation and T cell exclusion, facilitating the immune escape of DCSCs, and QSOX1 inhibition, combined with immunotherapy and chemotherapy, represents a promising therapeutic approach for eliminating DCSCs and preventing recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesB7-H1 AntigenEsophageal NeoplasmsNeoplastic Stem CellsHumansAnimalsMiceOxidoreductases Acting on Sulfur Group DonorsUp-RegulationTumor EscapeCell Line, TumorOrganoselenium CompoundsGene Expression Regulation, NeoplasticReactive Oxygen Species

Stichwörter der Autor:innen

PD-1/PD-L1T cell exclusionesophageal cancer stem cellreactive oxygen speciestumor dormancy

Substanzen

B7-H1 AntigenCD274 protein, humanOxidoreductases Acting on Sulfur Group DonorsOrganoselenium CompoundsReactive Oxygen Species

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen Universi…
  • Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, Foshan 528200, People's Republic of China.
  • Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, People's Republic of China.
  • Department of Clinical Oncology, The University of Hong Kong, Hong Kong 00852, People's Republic of China.
  • State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.
  • Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China.

ORCID-Profile: Baifeng Zhang, Yan Li, Ying-Hui Zhu, Xin-Yuan Guan, Lei Li

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Guangzhou science and Technology Plan

Zitieren

APA

Wei, J. R., Zhang, B., Zhang, Y., Chen, W. M., Zhang, X. P., Zeng, T. T., Li, Y., Zhu, Y. H., Guan, X. Y., & Li, L. (2024). QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion. Proceedings of the National Academy of Sciences, 121(44). https://doi.org/10.1073/pnas.2407506121

Vancouver

Wei JR, Zhang B, Zhang Y, Chen WM, Zhang XP, Zeng TT, et al. QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion. Proceedings of the National Academy of Sciences. 2024;121(44). doi:10.1073/pnas.2407506121

BibTeX
@article{Wei2024,
  author = {Wei, Jia-Ru and Zhang, Baifeng and Zhang, Yu and Chen, Wo-Ming and Zhang, Xiao-Ping and Zeng, Ting-Ting and Li, Yan and Zhu, Ying-Hui and Guan, Xin-Yuan and Li, Lei},
  title = {QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {44},
  doi = {10.1073/pnas.2407506121}
}
Kostenlos starten →